Targeted Therapy For RET-Rearranged Non-Small Cell Lung Cancer: Clinical Development And Future Directions.

Ackermann, Christoph Jakob; Stock, Gustavo; Tay, Rebecca; Dawod, Mohammed; Gomes, Fabio; Califano, Raffaele

Ackermann, Christoph Jakob; Stock, Gustavo; Tay, Rebecca; Dawod, Mohammed; Gomes, Fabio; Califano, Raffaele.

Afiliação

Ackermann CJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Stock G; Department of Medical Oncology, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.
Tay R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Dawod M; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Gomes F; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Onco Targets Ther ; 12: 7857-7864, 2019.

Article em En | MEDLINE | ID: mdl-31576143

Palavras-chave

BLU-667; LOXO-292; NSCLC; RET; RXDX-105; selective RET-inhibition

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google